×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CRVO – cervomed inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CRVO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/14
06:30 pm
crvo
CervoMed Inc. (NASDAQ: CRVO) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $55.00 price target on the stock.
Low
Report
CervoMed Inc. (NASDAQ: CRVO) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $55.00 price target on the stock.
11/13
08:00 am
crvo
CervoMed Announces Key Senior Leadership Appointments
Medium
Report
CervoMed Announces Key Senior Leadership Appointments
11/12
07:00 am
crvo
CervoMed Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Low
Report
CervoMed Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
11/8
09:55 am
crvo
CervoMed Awarded the Prix Galien USA 2024 Prize for Best Startup
Low
Report
CervoMed Awarded the Prix Galien USA 2024 Prize for Best Startup
11/7
08:30 am
crvo
CervoMed to Participate in Upcoming Investor Conferences
Medium
Report
CervoMed to Participate in Upcoming Investor Conferences
11/4
08:00 am
crvo
CervoMed Announces Key Takeaways from Oral Presentations at the 17th Clinical Trials on Alzheimer's Disease Conference (CTAD)
High
Report
CervoMed Announces Key Takeaways from Oral Presentations at the 17th Clinical Trials on Alzheimer's Disease Conference (CTAD)
10/29
08:00 am
crvo
CervoMed to Deliver Oral Presentation at the 8th International Lewy Body Dementia Conference
Low
Report
CervoMed to Deliver Oral Presentation at the 8th International Lewy Body Dementia Conference
10/15
08:00 am
crvo
CervoMed Announces Last Patient Last Visit in Phase 2b RewinD-LB Trial of Neflamapimod for the Treatment of Early-Stage Dementia with Lewy Bodies (DLB)
Low
Report
CervoMed Announces Last Patient Last Visit in Phase 2b RewinD-LB Trial of Neflamapimod for the Treatment of Early-Stage Dementia with Lewy Bodies (DLB)
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
03:09 pm
crvo
Form SC 13G CervoMed Inc. Filed by: AWM Investment Company, Inc.
Low
Report
Form SC 13G CervoMed Inc. Filed by: AWM Investment Company, Inc.
11/13
04:02 pm
crvo
Form 8-K CervoMed Inc. For: Nov 08
Low
Report
Form 8-K CervoMed Inc. For: Nov 08
11/12
09:27 am
crvo
Form 10-Q CervoMed Inc. For: Sep 30
Low
Report
Form 10-Q CervoMed Inc. For: Sep 30
11/4
05:30 pm
crvo
Form 8-K CervoMed Inc. For: Nov 04
Low
Report
Form 8-K CervoMed Inc. For: Nov 04
10/30
08:00 am
crvo
Form 8-K CervoMed Inc. For: Oct 29
Medium
Report
Form 8-K CervoMed Inc. For: Oct 29
10/16
08:00 am
crvo
Form 8-K CervoMed Inc. For: Oct 15
Low
Report
Form 8-K CervoMed Inc. For: Oct 15
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: